A vaccine for activating CD8 T cells including Bacillus Calmette-Guérin (BCG bacteria) which express a protein derived from a pathogenic microorganism as an active ingredient is beneficial because it can activate pathogenic microorganism-derived-antigen-specific CD8 T cells